These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis. Przyklenk K; Kloner RA Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780 [TBL] [Abstract][Full Text] [Related]
15. Local intravenous thrombolysis with recombinant tissue plasminogen activator for salvage of forearm replantation. Hashim HA; Atiyeh BS; Hamdan AM; Musharrafieh RS J Reconstr Microsurg; 1996 Nov; 12(8):543-6. PubMed ID: 8951123 [TBL] [Abstract][Full Text] [Related]
17. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog. Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384 [TBL] [Abstract][Full Text] [Related]
18. Repeated successful thrombolysis of an acute peripheral arterial thrombosis with tissue plasminogen activator. Berridge DC; Gregson RH; Hopkinson BR; Makin GS J R Coll Surg Edinb; 1989 Feb; 34(1):49-51. PubMed ID: 2496228 [No Abstract] [Full Text] [Related]
19. Reteplase thrombolysis for treatment of mechanical valve thrombosis. Schultz SC; D Ambra P J Invasive Cardiol; 2003 Mar; 15(3):156. PubMed ID: 12612392 [No Abstract] [Full Text] [Related]